Q2 Sales Beat Estimates by 4% on Cellulose Pricing Gains, Loss Narrows Sharply
RYAM has more than doubled off its 52-week low of $3.351.
Summary
Rayonier Advanced Materials reported Q2 net sales of $376M, beating the $361M consensus by 4%, driven by higher cellulose specialties pricing from newly negotiated 2026 agreements. Adjusted EBITDA jumped 43% YoY, and the loss from continuing operations narrowed dramatically to $33M from $366M a year ago. The company reaffirmed its full-year outlook and expects positive free cash flow in 2026, with a strategic review conclusion planned for Q4. This follows a turbulent period marked by a rejected acquisition offer at a 100% premium in June, a new CEO appointment, and an activist investor disclosing a 5% stake in July. The results signal operational stabilization after a Q1 that included a $41M charge for idling a facility, though the shift toward lower-margin commodity production bears watching.
At the time of this announcement, RYAM was trading at $9.06 on NYSE in the Manufacturing sector, with a market capitalization of approximately $590.8M. The 52-week trading range was $3.35 to $11.85. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.